Nocistatin inhibits 5‐hydroxytryptamine release in the mouse neocortex via presynaptic Gi/oprotein linked pathways
- 1 October 2007
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 152 (4) , 549-555
Abstract
Background and purpose: Nocistatin (NST) is a neuropeptide generated from cleavage of the nociceptin/orphanin FQ (N/OFQ) precursor. Evidence has been presented that NST acts as a functional antagonist of N/OFQ, although NST receptor and transduction pathways have not yet been identified. We previously showed that N/OFQ inhibited [3H]5‐hydroxytryptamine ([3H]5‐HT) release from mouse cortical synaptosomes via activation of NOP receptors. We now investigate whether NST regulates [3H]5‐HT release in the same preparation.Experimental approach: Mouse and rat cerebrocortical synaptosomes in superfusion, preloaded with [3H]5‐HT and stimulated with 1 min pulses of 10 mM KCl, were used.Key results: Bovine NST (b‐NST) inhibited the K+‐induced [3H]5‐HT release, displaying similar efficacy but lower potency than N/OFQ. b‐NST action underwent concentration‐dependent and time‐dependent desensitization, and was not prevented either by the NOP receptor antagonist [Nphe1Arg14,Lys15]N/OFQ(1‐13)‐NH2(UFP‐101) or by the non‐selective opioid receptor antagonist, naloxone. Contrary to N/OFQ, b‐NST reduced [3H]5‐HT release from synaptosomes obtained from NOP receptor knockout mice. However, both N/OFQ and NST were ineffective in synaptosomes pre‐treated with the Gi/oprotein inhibitor,Pertussistoxin. NST‐N/OFQ interactions were also investigated. Co‐application of maximal concentrations of both peptides did not result in additive effects, whereas pre‐application of maximal b‐NST concentrations partially attenuated N/OFQ inhibition.Conclusions and implications: We conclude that b‐NST inhibits [3H]5‐HT release via activation of Gi/oprotein linked pathways, not involving classical opioid receptors and the NOP receptor. The present data strengthen the view that b‐NST is,per se, a biologically active peptide endowed with agonist activity.British Journal of Pharmacology(2007)152, 549–555; doi:10.1038/sj.bjp.0707377; published online 9 July 2007Keywords
This publication has 41 references indexed in Scilit:
- Transcriptional profiling of brain‐derived‐neurotrophic factor‐induced neuronal plasticity: A novel role for nociceptin in hippocampal neurite outgrowthJournal of Neurobiology, 2006
- Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5‐hydroxytryptamine release in the mouse neocortexEuropean Journal of Neuroscience, 2004
- Nocistatin and Prepro-Nociceptin/Orphanin FQ 160–187 Cause Nociception through Activation of Gi/o in Capsaicin-Sensitive and of Gs in Capsaicin-Insensitive Nociceptors, RespectivelyThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5‐hydroxytryptamine and noradrenaline release in the rat neocortexBritish Journal of Pharmacology, 2003
- Inhibitory action of nociceptin/orphanin FQ on functionally different thalamic neurons in urethane‐anaesthetized ratsBritish Journal of Pharmacology, 2001
- Modulation of 5‐hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptinBritish Journal of Pharmacology, 2000
- Characterization of [Nphe1]nociceptin(1‐13)NH2, a new selective nociceptin receptor antagonistBritish Journal of Pharmacology, 2000
- Nociceptin, Phe1ψ‐nociceptin1–13, nocistatin and prepronociceptin154–181 effects on calcium channel currents and a potassium current in rat locus coeruleus in vitroBritish Journal of Pharmacology, 1999
- Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: Comparison of ORL1 receptor mRNA expression with125I-[14Tyr]-orphanin FQ bindingJournal of Comparative Neurology, 1999
- Effects of nociceptin and nocistatin on antidromic vasodilatation in hairless skin of the rat hindlimb in vivoBritish Journal of Pharmacology, 1999